Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.72 USD | +4.17% | -0.45% | +89.69% |
06-24 | Harrow, Inc.(NasdaqGM:HROW) added to S&P Pharmaceuticals Select Industry Index | CI |
06-21 | Craig-Hallum Adjusts Price Target on Harrow Health to $30 From $26, Buy Rating Maintained | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+89.69% | 738M | |
+56.70% | 816B | |
+39.55% | 634B | |
-6.77% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.49% | 238B | |
+1.02% | 222B | |
+13.41% | 218B | |
+8.51% | 167B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- Transcript : Harrow, Inc., Q4 2023 Earnings Call, Mar 20, 2024